Less than a year after buying a U.S. plant from AstraZeneca, Novartis’ biotech AveXis has it ready for production of Zolgensma, its gene therapy for spinal muscular atrophy. The new plant will help it get the treatment for the rare genetic disease to more patients. It also is building a plant in North Carolina that… Read More »
The trial to stop a former Optum employee from working for the healthcare venture formed by Amazon, Berkshire Hathaway and JPMorgan Chase, has shed light on what the new enterprise intends to do this year. In Massachusetts District Court, David W. Smith, former Optum vice president of Product/Corporate Strategy, said the new company isn’t looking… Read More »
When it comes to working, few people can confess that they love their jobs. While Australians are up there with the happiest of the lot – we’re the 11th happiest bunch of workers globally – there are always things that we can be doing to improve workplace conditions for employees so that they can feel… Read More »